Clinical Social Workers in Brookings, SD Accepting Medicare

4 Clinical Social Workers found. Showing 1 - 4

Jacalyn Person, CSW-PIP Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 922 22nd Ave S, Brookings, SD 57006 Phone: 605-697-1900    Fax: 605-697-1919

Curstie Konold Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1024 6th St Ste B, Brookings, SD 57006 Phone: 605-692-5730

Mark Francisco, LCSW-PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1451 6th St, Brookings, SD 57006 Phone: 605-670-8989

Michael Falconer, CSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 601 4th St, Ste 101, Brookings, SD 57006 Phone: 605-322-4079

News Archive

Anthrax scare due to lab mix up

A mistake at the laboratory that did the initial testing as a result of the anthrax scare at the Pentagon, has been blamed for the false alarms which saw hospitals alerted, 900 workers prescribed antibiotics, and closed three area mail facilities that handle Pentagon-bound mail.

Women who have migraines with aura have a more than 50 percent increased risk of total stroke and 70 percent increase of ischemic stroke

Women who have migraines with aura have a more than 50 percent increased risk of total stroke and 70 percent increase of ischemic stroke compared to those without migraines, according to research that will be presented at the American Academy of Neurology 56th Annual Meeting

UIC surgeons first to use robot for living-donor kidney-pancreas transplant

Surgeons at the University of Illinois Medical Center at Chicago are the first in the world to use robotic surgery to successfully remove a kidney and pancreas from a living-donor as part of a successful transplantation.

University of Kentucky receives Department of Defense grant for lung cancer study

The University of Kentucky's Dr. Susanne Arnold and colleagues were awarded a grant by the Department of Defense to study potential environmental reasons for the high lung cancer rates in Eastern Kentucky.

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.

Read more Medical News

› Verified 4 days ago